Suppr超能文献

泰国志贺氏菌病抗菌治疗的反应

Response to antimicrobial therapy for shigellosis in Thailand.

作者信息

Lolekha S, Vibulbandhitkit S, Poonyarit P

机构信息

Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S342-6. doi: 10.1093/clinids/13.supplement_4.s342.

Abstract

Shigella species have been one of the most common causes of acute diarrhea in Bangkok, Thailand. The incidence of shigellosis increased steadily from 1984 to 1988. The majority of Shigella species isolated from specimens from patients with acute diarrhea in Bangkok in 1988 were resistant to both ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ). Shigella flexneri was the most commonly isolated organism and had the highest rate of resistance to ampicillin, chloramphenicol, TMP-SMZ, and tetracycline. The antimicrobial agents of choice for the treatment of shigellosis have been changed from ampicillin to TMP-SMZ and recently to the fluoroquinolones. We conducted a controlled study of norfloxacin that revealed its efficacy for eradication of Shigella species from the stool of both adults and children. The fluoroquinolones shorten the course of diarrhea, reduce the shedding of the organism, and prevent the spread of infection. No short-term adverse effects of the quinolones were observed in this study; however, its use among children should be restricted to treatment of severe shigellosis and the duration of treatment should be as short as possible.

摘要

志贺氏菌属一直是泰国曼谷急性腹泻最常见的病因之一。1984年至1988年期间,志贺氏菌病的发病率稳步上升。1988年从曼谷急性腹泻患者标本中分离出的大多数志贺氏菌属对氨苄青霉素和甲氧苄啶-磺胺甲恶唑(TMP-SMZ)均耐药。福氏志贺氏菌是最常分离出的菌株,对氨苄青霉素、氯霉素、TMP-SMZ和四环素的耐药率最高。治疗志贺氏菌病的首选抗菌药物已从氨苄青霉素改为TMP-SMZ,最近又改为氟喹诺酮类。我们进行了一项关于诺氟沙星的对照研究,结果显示其对清除成人和儿童粪便中的志贺氏菌属有效。氟喹诺酮类可缩短腹泻病程,减少病菌排出,并防止感染传播。本研究未观察到喹诺酮类药物的短期不良反应;然而,儿童使用该药应仅限于治疗严重志贺氏菌病,且治疗时间应尽可能短。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验